Q&A: Gregory Heath on Early Lessons from Illumina's Clinical Sequencing Program
April 05, 2011
Q&A: Gregory Heath on Early Lessons from Illumina's Clinical Sequencing Program
Gregory Heath, senior vice president and general manager of diagnostics at Illumina, spoke with Clinical Sequencing News about the company's experience with sequencing patient genomes, the challenges it has faced, and what he sees as the future of clinical sequencing.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- TCGA Study Provides 'Roadmap' for Targeted Therapy, Genomic Subtyping in Ovarian Cancer
June 29, 2011 / Clinical Sequencing News - UK Government Funding Development of Sequencing-Based Cancer Tests
June 21, 2011 / Clinical Sequencing News - Transgenomic Launches NGS-Based Mitochondrial Disease Test, Developing Autism Risk Test
June 21, 2011 / Clinical Sequencing News - Exome Sequencing IDs Druggable BRAF Mutation in 47 HCL Patients
June 15, 2011 / Clinical Sequencing News - Foundation Medicine Shows Sequencing-based Cancer Test Can ID Clinically Actionable Mutations
June 8, 2011 / Clinical Sequencing News